Measurement of cell-mediated cytotoxicity using flow cytometry
18. tibodies. Proc Natl Acad Sci USA 83:7785-7789, 1986. 12. Arceci RJ, Stieglitz K, Bras J, et al.: Monoclonal antibody to an external epitope of the human mdrl P-glycoprotein. Cancer Res 53:310-317, 1993. 13. Chaudhary PM, Mechetoer EB, Roninson IB: Expression and activity of the muitidmg resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735-2739, 1992. 14. Speth PAI, Linssen PCM, Boezeman JBM, et al.: Quantitation of anthracyclines in human hematopoietic cell sublx~pulations by flow cytometry correlated with high pressure liquid chromatography. Cytometry 6:143-150, 1985. 15. Luk CK, Tannock IF: Flow cytometric analysis of doxombicin accumulation in cells from human and rodent cell lines. J Natl Cancer Inst 81:5559, 1989. 16. Krishan A Sridhar KS, Davila E, et al.: Patterns of anthracycline retention modulation in human tumor cells. Cytometry 8:306-314, 1987. 17. Herwijer H, Sonneveld P, Baas F, et al.: Expression of mdrl and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drog accumulation by cyclosporine. J Natl Cancer Inst 82:11331140, 1990. Gheuens EE, et al.: Flow cytometric double labeling technique for screening of multidmg resistance. Cytometry 12:636-644, 1991. 19. Ludescher C, Thaler J, Drach D, et al.: Detection of activity of P-glycoprotein in human turnout samples using rhodamine 123. Br J Haematol 82:161-168, 1992. 20. Dordal MS, Winter JN, Atkinson AJ Jr.: Kinetic analysis of P-glycoprotein-mediated doxorubicin efflux. J Pharmacol Exp Ther 263:762-766, 1992. 21. Emaus RK, Grunwald R, Lemasters JJ: Rhodamine-123 as a probe of transmembrane potential in isolated rat-liver mitochondria: Spectral and metabolic properties. Biochim Biophys Acta